A detailed history of North Crest Asset Manangement, LLC transactions in Dexcom Inc stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 24,939 shares of DXCM stock, worth $1.72 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
24,939
Previous 26,076 4.36%
Holding current value
$1.72 Million
Previous $2.96 Million 43.47%
% of portfolio
0.05%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$64.0 - $116.06 $72,768 - $131,960
-1,137 Reduced 4.36%
24,939 $1.67 Million
Q2 2024

Jul 16, 2024

BUY
$110.31 - $140.45 $289,563 - $368,681
2,625 Added 11.19%
26,076 $2.96 Million
Q1 2024

Apr 15, 2024

SELL
$114.22 - $140.1 $31,981 - $39,228
-280 Reduced 1.18%
23,451 $3.25 Million
Q4 2023

Jan 30, 2024

SELL
$75.49 - $124.16 $28,686 - $47,180
-380 Reduced 1.58%
23,731 $2.94 Million
Q3 2023

Nov 13, 2023

SELL
$86.06 - $137.93 $27,969 - $44,827
-325 Reduced 1.33%
24,111 $2.25 Million
Q2 2023

Jul 21, 2023

SELL
$112.47 - $130.98 $90,875 - $105,831
-808 Reduced 3.2%
24,436 $3.14 Million
Q1 2023

Apr 25, 2023

BUY
$104.0 - $122.92 $47,528 - $56,174
457 Added 1.84%
25,244 $2.93 Million
Q4 2022

Feb 01, 2023

BUY
$84.98 - $122.67 $81,835 - $118,131
963 Added 4.04%
24,787 $2.81 Million
Q3 2022

Oct 17, 2022

BUY
$76.35 - $94.18 $17,789 - $21,943
233 Added 0.99%
23,824 $1.92 Million
Q2 2022

Jul 18, 2022

BUY
$67.99 - $132.89 $1.23 Million - $2.4 Million
18,052 Added 325.91%
23,591 $1.76 Million
Q1 2022

Apr 18, 2022

BUY
$94.08 - $130.2 $77,427 - $107,154
823 Added 17.45%
5,539 $2.83 Million
Q4 2021

Feb 09, 2022

BUY
$129.87 - $162.82 $612,466 - $767,859
4,716 New
4,716 $2.53 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.